title: Tardive dystonia. The benefits of time.
abstract: Tardive dystonia is a rare movement disorder. We outline the development of tardive dystonia in a young schizophrenic, and demonstrate the importance of applying a double-blind, placebo-controlled, cross-over trial of any putative successful treatment.
authors.affiliation: Department of Mental Health, Queen's University of Belfast.
authors.forename: S J
authors.initials: SJ
authors.lastname: Cooper
authors.forename: M M
authors.initials: MM
authors.lastname: Doherty
authors.forename: D J
authors.initials: DJ
authors.lastname: King
mesh_terms: D000328:Adult; D002746:Chlorpromazine / Q000008:administration & dosage / Q000009:adverse effects*; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D004359:Drug Therapy, Combination; D004409:Dyskinesia, Drug-Induced / Q000188:drug therapy*; D005476:Fluphenazine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D006801:Humans; D008297:Male; D011433:Propranolol / Q000008:administration & dosage*; D012559:Schizophrenia / Q000188:drug therapy*; D012565:Schizophrenic Psychology
chemical_list: D011433:Propranolol; C011825:fluphenazine depot; D005476:Fluphenazine; D002746:Chlorpromazine